Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Vera Battini, Giovanna Cirnigliaro, Luca Giacovelli, Maria Boscacci, Silvia Massara Manzo, Giulia Mosini, Greta Guarnieri, Michele Gringeri, Beatrice Benatti, Emilio Clementi, Bernardo Dell’Osso & Carla Carnovale. (2023) Psychiatric and non-psychiatric drugs causing false-positive amphetamines urine test in psychiatric patients: a pharmacovigilance analysis using FAERS. Expert Review of Clinical Pharmacology 16:5, pages 453-465.
Read now
Read now
Michael R. Christian, Jennifer A. Lowry, D. Adam Algren, Stephen L. Thornton, Shuang Deng & Uttam Garg. (2017) Do rapid comprehensive urine drug screens change clinical management in children?. Clinical Toxicology 55:9, pages 977-980.
Read now
Read now
Ryan Abbott$suffix/text()$suffix/text() & David E. Smith$suffix/text()$suffix/text(). (2015) The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis. Journal of Psychoactive Drugs 47:5, pages 368-371.
Read now
Read now
Articles from other publishers (43)
Jiayu Jiang, Lixian Wen, Hongshuang Wang, Xiaoguang Chen, Yanchuan Zhao & Xiaohui Wang. (2023) Detection and identification of amphetamine-type stimulants and analogs via recognition-enabled “chromatographic” 19F NMR. Journal of Fluorine Chemistry 266, pages 110085.
Crossref
Crossref
Jianhua Xiong, Xiangting Wei, Xiantao Shen, Weiwei Zhu, Shaohua Yi & Chuixiu Huang. (2023) Synthesis of molecularly-imprinted polymers towards a group of amphetamine-type stimulants by reflux precipitation polymerization with a pseudo template. Journal of Chromatography A 1688, pages 463738.
Crossref
Crossref
Jeffrey D Pope, Olaf H Drummer & Hans G Schneider. (2022) False-Positive Amphetamines in Urine Drug Screens: A 6-Year Review. Journal of Analytical Toxicology.
Crossref
Crossref
Chen Li, Dongfang Han, Zhishan Liang, Fangjie Han, Wencai Fu, Wei Wang, Dongxue Han, Yukai Wang & Li Niu. (2022) Novel electrochemical-surface plasmon resonance (EC-SPR) sensor for amphetamine-type stimulants detection based on molecularly imprinted strategy. Sensors and Actuators B: Chemical 369, pages 132258.
Crossref
Crossref
Maria Nieddu, Elena Baralla, Valeria Pasciu, Maria Grazia Rimoli & Gianpiero Boatto. (2022) Cross-reactivity of commercial immunoassays for screening of new amphetamine designer drugs. A review. Journal of Pharmaceutical and Biomedical Analysis 218, pages 114868.
Crossref
Crossref
Roy R. Gerona & Deborah French. 2022.
217
263
.
Ana-Maria Dragan, Marc Parrilla, Bogdan Feier, Radu Oprean, Cecilia Cristea & Karolien De Wael. (2021) Analytical techniques for the detection of amphetamine-type substances in different matrices: A comprehensive review. TrAC Trends in Analytical Chemistry 145, pages 116447.
Crossref
Crossref
Dmitriy V. Sotnikov, Anatoly V. Zherdev, Elena A. Zvereva, Sergei A. Eremin & Boris B. Dzantiev. (2021) Changing Cross-Reactivity for Different Immunoassays Using the Same Antibodies: Theoretical Description and Experimental Confirmation. Applied Sciences 11:14, pages 6581.
Crossref
Crossref
Caroline Sprengel Lima, Melina Mottin, Leticia Ribeiro de Assis, Nathalya Cristina de Moraes Roso Mesquita, Bruna Katiele de Paula Sousa, Lais Durco Coimbra, Karina Bispo-dos- Santos, Kimberley M. Zorn, Rafael V.C. Guido, Sean Ekins, Rafael Elias Marques, José Luiz Proença-Modena, Glaucius Oliva, Carolina Horta Andrade & Luis Octavio Regasini. (2021) Flavonoids from Pterogyne nitens as Zika virus NS2B-NS3 protease inhibitors. Bioorganic Chemistry 109, pages 104719.
Crossref
Crossref
Silje Skrede, Jon Andsnes Berg, Kjell Ove Fossan, Christoffer Bartz-Johannessen, Else-Marie Løberg, Rune Andreas Kroken & Erik Johnsen. (2021) Illicit substances detected through high-resolution MS analysis in urine samples are associated with greater symptom burden in patients with psychosis. Emerging Trends in Drugs, Addictions, and Health 1, pages 100024.
Crossref
Crossref
Kenichi Tamama. 2021.
191
214
.
Satrya Fajri Pratama, Azah Kamilah Muda, Yun-Huoy Choo, Ramon Carbó-Dorca & Ajith Abraham. 2021. Proceedings of the 11th International Conference on Soft Computing and Pattern Recognition (SoCPaR 2019). Proceedings of the 11th International Conference on Soft Computing and Pattern Recognition (SoCPaR 2019)
90
101
.
Ashraf Mina. (2020) Comparison of several immunoassays used in drugs of abuse screening: Assessment against gold standard methods and calculation of measurement uncertainty. Journal of Pharmacological and Toxicological Methods 101, pages 106649.
Crossref
Crossref
Jacob J Hughey & Jennifer M Colby. (2019) Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records. Clinical Chemistry 65:12, pages 1522-1531.
Crossref
Crossref
Christina D. Martinez-Brokaw, Joshua B. Radke, Joshua G. Pierce, Alexandra Ehlers, Sean Ekins, Kelly E. Wood, Jon Maakestad, Jacqueline A. Rymer, Kenichi Tamama & Matthew D. Krasowski. (2019) Accidental intoxications in toddlers: lack of cross-reactivity of vilazodone and its urinary metabolite M17 with drug of abuse screening immunoassays. BMC Clinical Pathology 19:1.
Crossref
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Crossref
Anna Šuláková, Lucie Fojtíková, Barbora Holubová, Kateřina Bártová, Oldřich Lapčík & Martin Kuchař. (2019) Two immunoassays for the detection of 2C-B and related hallucinogenic phenethylamines. Journal of Pharmacological and Toxicological Methods 95, pages 36-46.
Crossref
Crossref
Amitava Dasgupta. 2019. Biotin and Other Interferences in Immunoassays. Biotin and Other Interferences in Immunoassays
113
132
.
Kenichi Tamama & Michael J. Lynch. 2020. Substance Use Disorders. Substance Use Disorders
463
502
.
Matthew D. Krasowski & Sean Ekins. 2018. Computational Toxicology. Computational Toxicology
175
209
.
Anja BegemanEric J. F. Franssen. (2018) Lack of Detection of New Amphetamine-Like Drugs Using Conventional Urinary Immunoassays. Therapeutic Drug Monitoring 40:1, pages 135-139.
Crossref
Crossref
Justine M. Reschly-Krasowski & Matthew D. Krasowski. (2018) A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing. Academic Pathology 5, pages 2374289518811797.
Crossref
Crossref
Satrya Fajri Pratama, Azah Kamilah Muda, Yun-Huoy Choo & Ajith Abraham. 2018. Hybrid Intelligent Systems. Hybrid Intelligent Systems
252
261
.
Anders Helander. 2017. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation. Detection of Drug Misuse: Biomarkers, Analytical Advances and Interpretation
83
99
.
D. French. 2017.
153
198
.
Amitava Dasgupta. 2017. Alcohol, Drugs, Genes and the Clinical Laboratory. Alcohol, Drugs, Genes and the Clinical Laboratory
167
191
.
Paul R. Smith & Stephen R. Morley. 2017. Essentials of Autopsy Practice. Essentials of Autopsy Practice
59
85
.
Pai-Shan Chen, Shu-Hua Chen, Jung-Hsuan Chen, Wan-Yun Haung, Hsin-Tung Liu, Po-Hsin Kong & Olivia Hsu-Yuan Yang. (2016) Modifier-assisted differential mobility–tandem mass spectrometry method for detection and quantification of amphetamine-type stimulants in urine. Analytica Chimica Acta 946, pages 1-8.
Crossref
Crossref
Jillian R. Neifeld, Laura E. Regester, Justin M. Holler, Shawn P. Vorce, Joseph MagluiloJrJr, Gerardo Ramos & Thomas Z. Bosy. (2016) Ultrafast Screening of Synthetic Cannabinoids and Synthetic Cathinones in Urine by RapidFire-Tandem Mass Spectrometry. Journal of Analytical Toxicology 40:5, pages 379-387.
Crossref
Crossref
Hua-Yang Liao, Jung-Hsuan Chen, Jing-Jong Shyue, Chia-Tung Shun, Huei-Wen Chen, Su-Wei Liao, Chih-Kang Hong & Pai-Shan Chen. (2015) Rapid label-free determination of ketamine in whole blood using secondary ion mass spectrometry. Talanta 143, pages 50-55.
Crossref
Crossref
Guanhua Ai, Caiping Tian, Dawei Deng, Guissi Fida, Haiyan Chen, Yuxiang Ma, Li Ding & Yueqing Gu. (2015) A combination of 2D similarity search, pharmacophore, and molecular docking techniques for the identification of vascular endothelial growth factor receptor-2 inhibitors. Anti-Cancer Drugs 26:4, pages 399-409.
Crossref
Crossref
Laura E. Regester, Jeffrey D. Chmiel, Justin M. Holler, Shawn P. Vorce, Barry Levine & Thomas Z. Bosy. (2015) Determination of Designer Drug Cross-Reactivity on Five Commercial Immunoassay Screening Kits. Journal of Analytical Toxicology 39:2, pages 144-151.
Crossref
Crossref
Matthew D. Krasowski, Andy Schriever, Gagan Mathur, John L. Blau, Stephanie L. Stauffer & Bradley A. Ford. (2015) Use of a data warehouse at an academic medical center for clinical pathology quality improvement, education, and research. Journal of Pathology Informatics 6:1, pages 45.
Crossref
Crossref
Mark J. Burish, Katie L. Thoren, Maura Madou, Shahed Toossi & Maulik Shah. (2014) Hallucinogens Causing Seizures? A Case Report of the Synthetic Amphetamine 2,5-Dimethoxy-4-Chloroamphetamine. The Neurohospitalist 5:1, pages 32-34.
Crossref
Crossref
Matthew D Krasowski & Sean Ekins. (2014) Using cheminformatics to predict cross reactivity of “designer drugs” to their currently available immunoassays. Journal of Cheminformatics 6:1.
Crossref
Crossref
Matthew D Krasowski, Denny Drees, Cory S Morris, Jon Maakestad, John L Blau & Sean Ekins. (2014) Cross-reactivity of steroid hormone immunoassays: clinical significance and two-dimensional molecular similarity prediction. BMC Clinical Pathology 14:1.
Crossref
Crossref
Magdalene H.Y. Tang, C.K. Ching, Caroline Y.W. Lee, Ying-Hoo Lam & Tony W.L. Mak. (2014) Simultaneous detection of 93 conventional and emerging drugs of abuse and their metabolites in urine by UHPLC-MS/MS. Journal of Chromatography B 969, pages 272-284.
Crossref
Crossref
Nathalie Allibe, Hélène Eysseric-Guérin, Xavier Fonrose, Mireille Bartoli, Marianne Barbieux & Françoise Stanke-Labesque. (2014) Une interférence analytique peut en cacher une autre : l’exemple de l’urapidil, du dépistage de MDMA et de l’identification d’un stimulant de synthèse, la 2-MeOPP. Toxicologie Analytique et Clinique 26:3, pages 128-132.
Crossref
Crossref
Megan E. Musselman & Jeremy P. Hampton. (2014)
“
Not for Human Consumption”: A Review of Emerging Designer Drugs
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:7, pages 745-757.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging drugs of abuse. Disease-a-Month 60:3, pages 110-132.
Crossref
Crossref
Olof Beck, Linnea Rausberg, Yasir Al-Saffar, Tomas Villen, Lennart Karlsson, Therese Hansson & Anders Helander. (2014) Detectability of new psychoactive substances, ‘legal highs’, in CEDIA, EMIT, and KIMS immunochemical screening assays for drugs of abuse. Drug Testing and Analysis, pages n/a-n/a.
Crossref
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
Crossref
Yan Zhang & Tai C. Kwong. (2014) Utilization management in toxicology. Clinica Chimica Acta 427, pages 158-166.
Crossref
Crossref